Abstract: A rubber composition suited for forming a truck tire tread includes 100 phr of elastomers, including a natural rubber and a styrene-butadiene rubber. A ratio by weight of natural rubber to styrene-butadiene rubber is at least 50:50. The composition further includes at least 45 phr of reinforcing fillers, including carbon black and a high surface area silica. The high surface area silica has a CTAB surface area of at least 220 m2/g. A ratio of the carbon black to the high surface area silica is at least 4:1. The composition further includes one or more processing aids and a sulfur-containing cure package.

Abstract: Disclosed is a composition comprising an effective amount of a mixture of inactivated Escherichia coli and Enterococcus faecalis as well as pharmaceutically acceptable excipients and/or carriers for use in the treatment, supportive treatment or prevention of dermatologic conditions and diseases.

Abstract: Disclosed is a composition comprising an effective amount of a mixture of inactivated Escherichia coli and Enterococcus faecalis as well as pharmaceutically acceptable excipients and/or carriers for use in the treatment, supportive treatment or prevention of dermatologic conditions and diseases.

Abstract: The present invention is applicable in the fields of finance, health care, employee benefits, math, and business statistics and was originated to provide real health-care decision analysis, risk analysis, and option analytics to corporate entities and individual participants, the need for which has arisen from what is collectively known as the Affordable Care Act (Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act of 2010). The present version of the Health Quant Data Modeler (HQDM) accounts for updates made necessary by the implementation of the Affordable Care Act, including additional applications for modeling, simulating, and analyzing the financial impact of the health-care real options for corporate entities with a minimal set of input assumptions for the purposes of a rapid economic justification and analysis.

Abstract: The present invention provides analytic utilities to an employer or health plan administrator as the financial underwriter of medical, prescription drug, and disability income protection for employees. It is specifically designed to integrate the use of evidence based clinical performance data and prescription drug possession ratios as part of a network optimization application; provide insights into disease progression and population migration over multiple time periods; calculate the impact on productivity as result of risk levels and health conditions; and make available advanced financial modeling capabilities utilizing econometric models and simulation.

Abstract: The present invention is adapted to provide real health-care decision analysis, risk analysis, and option analytics to individual participants, the need for which has arisen from the passage of the Affordable Care Act. The system and process simulate, optimize and visualize individual health plan options. The optimization utility uses the carrier component pricing, actuarial value calculations and phantom rate development as the basis of valuation for each of the medical and pharmacy benefit plan design permutations. Employer sponsored insurance funding, legislated premium tax credits and cost sharing reductions and individual account based funding are all factored into the process. A detailed preference analytics algorithm is used to formulate the appropriate individual risk profile in order to map the options. The individual has the ability to simulate customized scenarios as part of the tier paths defined in the Affordable Care Act.

Abstract: Embodiments of the present invention are applicable in the field of finance, health care, employee benefits, math, and business statistics and are originated to provide real health-care decision analysis, risk analysis, and option analytics to corporate entities and individual participants, the need for which has arisen from the passage of the Patient Protection and Affordable Care Act. The present Health Quant Data Modeler (HQDM) invention is designed as an application that integrates optimization, cohort analysis, forecasting, real options, and risk-based Monte Carlo simulation into a comprehensive utility for corporations as well as individuals in order to make better health-care related decisions.